Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP4290844B2 - Method for producing theanine - Google Patents
[go: Go Back, main page]

JP4290844B2 - Method for producing theanine - Google Patents

Method for producing theanine Download PDF

Info

Publication number
JP4290844B2
JP4290844B2 JP2000088975A JP2000088975A JP4290844B2 JP 4290844 B2 JP4290844 B2 JP 4290844B2 JP 2000088975 A JP2000088975 A JP 2000088975A JP 2000088975 A JP2000088975 A JP 2000088975A JP 4290844 B2 JP4290844 B2 JP 4290844B2
Authority
JP
Japan
Prior art keywords
group
anhydride
glutamic acid
theanine
glutamic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000088975A
Other languages
Japanese (ja)
Other versions
JP2001278848A (en
Inventor
勢津子 安東
隆巳 角田
Original Assignee
株式会社 伊藤園
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社 伊藤園 filed Critical 株式会社 伊藤園
Priority to JP2000088975A priority Critical patent/JP4290844B2/en
Publication of JP2001278848A publication Critical patent/JP2001278848A/en
Application granted granted Critical
Publication of JP4290844B2 publication Critical patent/JP4290844B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【0001】
【産業上の利用分野】
本発明は、ペプチド合成によりL−グルタミン酸−γ−エチルアミド(L−テアニン)を製造する方法であって、特に食品添加剤として安全に使用できるテアニンの製造方法に関する。
【0002】
【従来の技術及び発明が解決しようとする課題】
お茶のうま昧成分として知られているテアニンは、カフェイン興奮抑制作用、血圧降下作用、リラックス作用、脳機能改善作用などの有用性が知られている。しかし、茶葉中に含まれるテアニン量はわずかに0.5〜2重量%で、茶ポリフェノールが10〜15重量%含まれているのに比べると非常に少ない。よって、茶葉から抽出したテアニンを産業的に利用することは量的にもコスト的にも実用的でなく、従来から食品添加物や医薬品原料として安価で安全なテアニン製造方法が求められてきた。
【0003】
従来のテアニンの化学合成法としては、実験室的製法として、グルタミン酸を塩酸存在下で無水エタノールと振り混ぜた後、低温下で過剰の塩酸とエタノールとを除き、析出した塩酸塩をメタノールに溶かし、この溶液に計算量のアンモニアを加えて冷却してLグルタミン酸−γ−エチルエステルを得、これをクロロカルボキシル酸ベンジルエステルと反応させてNカルボキシベンジル−Lグルタミン酸−γ−エチルエステルとし、次にこれをエチルアミンと反応させてN保護カルボキシベンジル−L−グルタミン酸−γ−エチルアミドとし、次いで白金触媒下で水秦添加してL−グルタミン酸−γ−エチルアミド(L−テアニン)を得る方法が開示されている(酒戸弥二郎ら:日農化誌23,269(1950))。
工業的製法としては、例えば特開平5−70419号公報等において、L−グルタミン酸のγ−カルボキシル基をベンジル化して保護すると共に、アミノ基をトリチル化して保護し、これをペプチド合成の出発原料とするテアニンの製造方法等が開示されている。
【0004】
しかしながら、従来の製法の多くは、高純度のテアニンを得られたとしても工程数が多く煩雑でしかも収率が低く、得られるテアニンは高価なものとなってしまうのが現実であった。例えば、グルタミン酸をペプチド合成の出発原料に使用する場合、γ−カルボキシル基をベンジルエステルで保護するのが一般的であったが、ベンジル基の脱離が困難であるため、工程数が多くなるか、工程時間が長くなるか、或いは反応の条件が過酷となるなどの問題があった。
一方、得られたテアニンを食品添加物や医薬品原料として使用することを考慮すると、純度を高くすることは勿論、人体に有害な縮合剤や金属をできるだけ使用しない製法が望まれる。
【0005】
そこで本発明者らは、より少ない工程で高純度のテアニンを高収率で得ることができ、しかも人体に有害な有機溶媒や金属をできるだけ使用しないテアニンの製造方法を提供すべく、特開2000−26383号において、グルタミン酸のα位のアミノ基をターシャルブチルオキシカルボニル基(Boc基)で保護し、かつカルボキシル基をターシャルブチルエステル基(OtBu基)で保護してなるグルタミン酸誘導体(Boc−Glu−OtBu)をペプチド合成の出発原料とし、これを溶媒に溶解し、この溶液に縮合剤と水溶性活性エステル試薬とを加えて尿素誘導体を析出させ、更にエチルアミン塩酸塩とpH調整剤との混液を加えてターシャルブチルオキシカルボニル−γ−エチルアミドグルタミン酸ターシャルブチルエステル(Boc−Glu(NHC2 H5 )−OtBu)を得、これを酸処理してα位のアミノ基及びカルボキシル基のOtBu基を脱離させるテアニンの製造方法を開示した。
【0006】
本発明は、上記開示方法とは異なる方法、具体的にはグルタミン酸無水物を出発物質とする方法によって、より一層少ない工程で安価かつ高純度のテアニンを高収率で得ることができ、しかも人体に有害な縮合剤や金属をできるだけ使用しないテアニンの製造方法を提供せんとするものである。
【0007】
【課題を解決するための手段】
かかる目的のための本発明は、グルタミン酸のアミノ基を保護したN保護グルタミン酸無水物を、ジメチルスルホキシド(以下「DMSO」と略す。)を用いて当該無水物のγ位を選択的にエチルアミド化させてN保護テアニンとし、当該N保護基を脱離させてテアニンとするものである。
【0008】
この製造方法の特徴は、グルタミン酸無水物をペプチド合成の出発原料とした点と、DMSOを用いて当該無水物のγ位を選択的にエチルアミド化した点にある。グルタミン酸無水物を出発原料とすれば、保護基は1個だけで済むから、アミノ基とカルボキシル基の両方を保護した出発物質に比べて、保護基の除去工程を軽減することができる。更に、このグルタミン酸無水物は、DMSOを用いることで、縮合剤を用いることなく開環及びアミノリシスをなさしめることができるから、その分製造コストを安価にすることができるばかりか、人体に対する安全性も高めることができる。また更に、DMSOを用いることでγ位を選択的にすなわちα位よりもγ位をより有利にエチルアミド化させることができ、テアニンの純度及び収率を飛躍的に高めることができる。
【0009】
本発明において、ペプチド合成の出発原料として用いる「グルタミン酸のアミノ基を保護したグルタミン酸無水物」としては、グルタミン酸のα位のアミノ基をベンジルオキシカルボニル基(Z基)で保護したZ−グルタミン酸無水物(Z−Glu−O)を用いるのが好ましい。このようにZ基をアミノ保護基とすれば、保護基の導入や除去が容易であるばかりか、ラセミ化を抑制することもでき、Z−グルタミン酸の結晶性もよい。しかも、接触還元のような温和で無害かつクリーンな方法で保護基を除去することもできる。
但し、本発明で用いるアミノ保護基は、Z基のみに限定されるものではない。そのほか、通常のペプチド合成にアミノ保護基として用いられるもの、例えばターシャルブチルオキシカルボニル(Boc)基や、その他のウレタン型保護基、ホルミル基やトシル基のようなアシル型保護基、トリチル基のようなアルキル型保護基なども用いることは可能である。Boc基は、エステル化の心配がない点で有利である。
【0010】
また、本発明において、グルタミン酸無水物のγ位を選択的にエチルアミド化させる具体的方法としては、例えば、Z−グルタミン酸無水物(Z−Glu−O)を、エチルアミン塩酸塩とトリエチルアミン又は炭酸水素ナトリウムの混液とともにDMSO中に加える方法を好ましく例示することができる。DMSO中で無水物は開環し、エチルアミンによりアミノリシスを受ける。この際、α位よりもγ位により優位にエチルアミンが導入される。実際、γ体:α体=3:1以上の割合でγ体を有利に得ることができることが実験で確かめられている。もっとも、α体とγ体は、シリカゲルクロマトグラフィーを使用すれば分離可能であることも本発明者は見出している。さらに、無水エチルアミンではなくエチルアミンの塩酸塩を用いることにより、通常のペプチド合成を行うときのように非常に穏和な条件下で反応を進めることができるメリットもある。
なお、トリエチルアミン、炭酸水素ナトリウムのいずれも使用することができるが、副生成物の生成が少ない点及び人体に対する安全性の点からすれば炭酸水素ナトリウムが優れている。
【0011】
【発明の実施の形態】
ここでは、Z−グルタミン酸無水物をペプチド合成の出発原料とし、以下の4工程を経て行うテアニン製造方法について説明する。
1)Z−グルタミン酸の合成
2)Z−グルタミン酸無水物の合成
3)Z−γ−エチルアミドグルタミン酸の合成
4)保護基の脱離及び精製
【0012】
1)Z−グルタミン酸の合成:グルタミン酸のZ化
グルタミン酸のZ化は、現在公知のあらゆる方法を採用することができる。例えば、塩化ベンジルオキシカルボニル(Z−Cl)を用いるSchotten-Baumann法のほか、p−ニトロフェニルエステル(Z−ONp)、N−ヒドロキシスクシンイミドエステル(Z−ONSu)その他の活性エステルを用いた方法などを挙げることができる。なお、市販のZ−グルタミン酸を用いることもできる。
【0013】
具体的合成例を挙げれば、グルタミン酸(H−Glu−OH)、トリメチルアミン(NEt3)及び水(H2O)を混ぜ合わせた溶液Aに、ベンジルオキシカルボニルスクシンイミド(Z−OSu)、アセトニトリル及びトリエチルアミン(NEt3)を混ぜ合わせた溶液Bを、攪拌させながら約20分かけて加え、反応終了後、当該反応溶液に塩酸を加えてpH2に調整し、これを水/酢酸エチルで分液抽出し、必要に応じて塩酸を加えて再び分液抽出し、得られた酢酸エチル層に硫酸ナトリウムを加えて乾燥させ、これを濾過し、減圧濃縮してオイルを得、氷冷下でエーテルを加えて結晶化させ、結晶を濾取することにより得ることができる。
【0014】
2)Z−グルタミン酸無水物の合成
無水酢酸中に、Z−グルタミン酸(Z−Glu−OH)を加え、加温し、得られた溶液を濃縮することによりZ−グルタミン酸無水物(Z−Glu−O)を得ることができる。
具体的には、無水酢酸(例えば75ml)中に攪拌しながらZ−グルタミン酸(10.4g)を加えて攪拌する(この際、溶液は懸濁する。)。この懸濁溶液の温度を非常にゆっくり(10分〜40分、好ましくは25分〜35分、中でも好ましいのは略30分かけて)、約50℃〜60℃、好ましくは約55℃付近まで上昇させ、この温度で約10〜30分、好ましくは15分〜25分、中でも好ましいのは約20分間程度攪拌し続ける(溶液は透明になる)。反応終了を薄層クロマトグラフィー(以下「TLC」と略す。)で確認した後、溶媒を濃縮し、得られたオイル状の物質を結晶化させることによりZ−グルタミン酸無水物を得ることができる。
【0015】
3)Z−γ−エチルアミドグルタミン酸の合成
Z−グルタミン酸無水物をDMSOに溶かす一方、エチルアミン塩酸塩とトリエチルアミン又は炭酸水素ナトリウムの混液をDMSOに溶かし、両方の溶液を加えて室温で20分間攪拌し、その後抽出・精製を行えば、目的のZ−γ−エチルアミドグルタミン酸を得ることができる。なお、この際使用するDMSOは、モレキュラーシーブ等で充分に乾燥させておく必要がある。
抽出・精製方法としては、例えば、炭酸水素ナトリウム(飽和10ml)と水10mlとを加え、水層をジクロロメタルで数度(例えば2度)抽出し、水層がPH1になるように酸性にする。その後、酢酸エチルで数度(例えば3度)抽出し、酢酸エチル層を硫酸マグネシウムで乾燥させ、溶媒を除去し、残渣のオイルを得た。そしてこのオイルを少量の酢酸エチルに溶解し、シリカゲルカラムで分離精製すれば、白色結晶のZ−γ−エチルアミドグルタミン酸を得ることができる。この際、酢酸エチルと酢酸(100:1)とで、早く溶出する方がα体(α位がエチルアミド化)で、遅く溶出する方がγ体(γ位がエチルアミド化)となるが、上記の方法によれば、γ体:α体=3:1以上の割合でγ位がエチルアミド化したγ体をより有利に得ることができる。
なお、溶出方法としては、溶離液を酢酸エチルのみで溶出させた後、その後5%メタノール酢酸エチル溶液、更にメタノール溶液で溶出させ、それぞれの分画溶液をTLCで確認後、溶離液を濃縮するという方法も挙げることができる。
【0016】
4)保護基の脱離及び精製
Z基の除去は、接触還元(水素添加)が温和で無害かつクリーンな方法である点で好ましい。具体的には、Z−γ-エチルアミドグルタミン酸を、塩酸を含むジオキサン溶液中でパラジウム等により接触還元すればよい。
なお、Z基の除去は、上記接触還元のほか、液体HFやスルホン酸類またはHBr/AcOHなどの酸処理によっても行うことができる。
【0017】
Z基を脱離した後は、パラジウム等を濾過し、溶媒を濃縮した後、エーテルで結晶化し、その後イオン交換樹脂(陽イオン交換樹脂:アンバーライトIR−124,Dowex50w−x12)で精製すればよい。
【0018】
(試験)
本試験では、Z-Glu anhyderide(無水物)の合成における反応時間と収率との関係について検討した。
【0019】
15mlの無水酢酸にZ−グルタミン酸(Z−Glu−OH)1.969mgを激しくかき混ぜながら加えて懸濁液を作成し、この懸濁液の温度をウォーターバスで室温〜55℃まで所定時間(10分、30分、60分)かけて上昇させた。そして、固体が全部溶解した後、20分〜60分間その温度を保って攪拌した。
その後、溶媒を減圧濃縮し、オイルを減圧デシケーター内の蒸発皿にて水酸化ナトリウムを入れたものと一緒に乾燥させた。
結晶化は、冷却しながらイソプロピルエーテル/石油エーテル(1/1,v/v)を少量ずつ加え、攪拌し続けた後、1時間で室温まで戻して結晶化させ、得られた結晶を冷却した石油エーテルで洗浄した。
下記表1には、昇温時間、反応時間及び収率の関係を示した。なお、表中の−は結晶として得ることができなかった結果を示している。
【0020】
【表1】

Figure 0004290844
【0021】
この結果、Z−グルタミン酸無水物を得るためには、懸濁溶液の温度を非常にゆっくり(約30分間かけて)55℃まで上昇させ、この温度で20分間程度攪拌し続けるのがよいことが判明した。
【0022】
【発明の効果】
本発明の製造は、ペプチド結合の出発物質として無水物を用いることで、カルボキシル保護基の導入・脱離工程を省くことができ、より一層少ない工程で高純度のテアニンを得ることができる。しかも、エチルアミンの導入は、無水物のアミノリシスによる開環反応で行うから、縮合剤を必要とせず、人体に対して安全であるばかりか、製造コストを非常に安価にすることができる。
また、アミノ基の保護基がZ基1個だけで済み、しかもZ基の脱離反応も接触還元(水素添加)で簡単に行うことができるメリットがある。
更に、人体に有害な有機溶媒や金属をほとんど使用してないから、食品添加物や医薬品原料として好適に利用することができる。[0001]
[Industrial application fields]
The present invention relates to a method for producing L-glutamic acid-γ-ethylamide (L-theanine) by peptide synthesis, and particularly to a method for producing theanine that can be safely used as a food additive.
[0002]
[Prior art and problems to be solved by the invention]
Theanine, which is known as a delicious component of tea, is known for its usefulness such as caffeine excitation suppression, blood pressure lowering, relaxation, and brain function improvement. However, the amount of theanine contained in the tea leaves is only 0.5 to 2% by weight, which is very small compared to 10 to 15% by weight of tea polyphenol. Therefore, industrially using theanine extracted from tea leaves is not practical in terms of quantity and cost, and there has been a demand for a cheap and safe method for producing theanine as a food additive or a pharmaceutical raw material.
[0003]
As a conventional chemical synthesis method for theanine, as a laboratory production method, glutamic acid is shaken with absolute ethanol in the presence of hydrochloric acid, excess hydrochloric acid and ethanol are removed at low temperature, and the precipitated hydrochloride is dissolved in methanol. The solution is added with the calculated amount of ammonia and cooled to obtain L-glutamic acid-γ-ethyl ester, which is reacted with chlorocarboxylic acid benzyl ester to give N-carboxybenzyl-L-glutamic acid-γ-ethyl ester, A method is disclosed in which this is reacted with ethylamine to form N-protected carboxybenzyl-L-glutamic acid-γ-ethylamide, and then added with syrup under a platinum catalyst to obtain L-glutamic acid-γ-ethylamide (L-theanine). (Saito Yajiro et al .: Nikko Kagaku 23,269 (1950)).
As an industrial production method, for example, in JP-A-5-70419 and the like, the γ-carboxyl group of L-glutamic acid is protected by benzylation, and the amino group is protected by tritylation, which is used as a starting material for peptide synthesis. A method for producing theanine is disclosed.
[0004]
However, in many of the conventional production methods, even if high-purity theanine can be obtained, the number of steps is complicated and the yield is low, and the theanine obtained is actually expensive. For example, when glutamic acid is used as a starting material for peptide synthesis, it was common to protect the γ-carboxyl group with a benzyl ester. However, it is difficult to remove the benzyl group, so the number of steps increases. However, there have been problems such as a long process time or severe reaction conditions.
On the other hand, in consideration of the use of the obtained theanine as a food additive or a pharmaceutical raw material, a production method is desired that not only increases the purity, but also uses a condensing agent or metal harmful to the human body as much as possible.
[0005]
In order to provide a method for producing theanine that can obtain high-purity theanine in a high yield with fewer steps and that uses as little an organic solvent or metal that is harmful to the human body as much as possible. No. 26263, a glutamic acid derivative (Boc-) in which the amino group at the α-position of glutamic acid is protected with a tertiary butyloxycarbonyl group (Boc group) and the carboxyl group is protected with a tertiary butyl ester group (OtBu group). Glu-OtBu) is used as a starting material for peptide synthesis, dissolved in a solvent, a condensing agent and a water-soluble active ester reagent are added to this solution to precipitate a urea derivative, and further, ethylamine hydrochloride and a pH adjuster A mixed liquid was added to add tert-butyloxycarbonyl-γ-ethylamidoglutamic acid tert-butyl ester (B oc-Glu (NHC2H5) -OtBu) was obtained, and this was acid-treated to disclose a theanine production method in which the α-position amino group and carboxyl group OtBu group were eliminated.
[0006]
According to the present invention, by using a method different from the above disclosed method, specifically, a method using glutamic anhydride as a starting material, inexpensive and high-purity theanine can be obtained in a high yield with fewer steps, and the human body. It is intended to provide a method for producing theanine that uses as little as possible a condensing agent or metal harmful to the environment.
[0007]
[Means for Solving the Problems]
For this purpose, the present invention provides an N-protected glutamic anhydride in which the amino group of glutamic acid is protected by selectively ethylamidating the γ position of the anhydride using dimethyl sulfoxide (hereinafter abbreviated as “DMSO”). N-protected theanine, and the N-protecting group is eliminated to give theanine.
[0008]
This production method is characterized in that glutamic anhydride is used as a starting material for peptide synthesis and that the γ position of the anhydride is selectively ethylamidated using DMSO. If glutamic anhydride is used as a starting material, only one protecting group is required, so that the step of removing the protecting group can be reduced compared to a starting material in which both the amino group and the carboxyl group are protected. Furthermore, since this glutamic anhydride can perform ring opening and aminolysis without using a condensing agent by using DMSO, not only can the production cost be reduced by that amount, but also safety to the human body. Can also be increased. Furthermore, by using DMSO, the γ position can be selectively amidated, that is, the γ position can be more advantageously ethylamidated than the α position, and the purity and yield of theanine can be dramatically increased.
[0009]
In the present invention, “glutamic acid anhydride in which the amino group of glutamic acid is protected” used as a starting material for peptide synthesis is a Z-glutamic acid anhydride in which the amino group at the α-position of glutamic acid is protected with a benzyloxycarbonyl group (Z group). It is preferable to use (Z-Glu-O). Thus, when the Z group is an amino protecting group, not only the protecting group can be easily introduced and removed, but also racemization can be suppressed, and the crystallinity of Z-glutamic acid is good. Moreover, the protecting group can be removed by a mild, harmless and clean method such as catalytic reduction.
However, the amino protecting group used in the present invention is not limited to the Z group. In addition, those used as amino protecting groups in normal peptide synthesis, such as tertiary butyloxycarbonyl (Boc) group, other urethane type protecting groups, acyl type protecting groups such as formyl group and tosyl group, trityl group Such alkyl-type protecting groups can also be used. The Boc group is advantageous in that there is no fear of esterification.
[0010]
In the present invention, specific methods for selectively ethylamidating the γ-position of glutamic anhydride include, for example, Z-glutamic anhydride (Z-Glu-O), ethylamine hydrochloride and triethylamine or sodium bicarbonate. A method of adding it to DMSO together with a mixed solution of can preferably be exemplified. The anhydride opens in DMSO and undergoes aminolysis with ethylamine. At this time, ethylamine is introduced more preferentially at the γ position than at the α position. In fact, experiments have confirmed that γ-form can be advantageously obtained at a ratio of γ-form: α-form = 3: 1 or more. However, the present inventor has also found that the α-form and the γ-form can be separated by using silica gel chromatography. Further, by using ethylamine hydrochloride instead of anhydrous ethylamine, there is also an advantage that the reaction can proceed under very mild conditions as in normal peptide synthesis.
Either triethylamine or sodium hydrogen carbonate can be used, but sodium hydrogen carbonate is superior from the viewpoint of the generation of by-products and the safety to the human body.
[0011]
DETAILED DESCRIPTION OF THE INVENTION
Here, a method for producing theanine, which is performed through the following four steps using Z-glutamic anhydride as a starting material for peptide synthesis, will be described.
1) Synthesis of Z-glutamic acid 2) Synthesis of Z-glutamic anhydride 3) Synthesis of Z-γ-ethylamidoglutamic acid 4) Removal and purification of protecting group
1) Synthesis of Z-glutamic acid: Z- formation of glutamic acid Z- formation of glutamic acid can employ any currently known method. For example, in addition to the Schotten-Baumann method using benzyloxycarbonyl chloride (Z-Cl), a method using p-nitrophenyl ester (Z-ONp), N-hydroxysuccinimide ester (Z-ONSu) and other active esters Can be mentioned. Commercially available Z-glutamic acid can also be used.
[0013]
As a specific synthesis example, a solution A in which glutamic acid (H-Glu-OH), trimethylamine (NEt3) and water (H2O) are mixed with benzyloxycarbonylsuccinimide (Z-OSu), acetonitrile and triethylamine (NEt3). Solution B mixed with was added over about 20 minutes with stirring. After the reaction was completed, hydrochloric acid was added to the reaction solution to adjust to pH 2, and this was separated and extracted with water / ethyl acetate. Add hydrochloric acid and separate and extract again.The resulting ethyl acetate layer is dried by adding sodium sulfate, filtered, concentrated under reduced pressure to give an oil, and ether is added to crystallize under ice-cooling. The crystal can be obtained by filtration.
[0014]
2) Synthesis of Z-glutamic anhydride Z-glutamic anhydride (Z-Glu-OH) was added to acetic anhydride, heated, and the resulting solution was concentrated to concentrate Z-glutamic anhydride ( Z-Glu-O) can be obtained.
Specifically, Z-glutamic acid (10.4 g) is added and stirred in acetic anhydride (for example, 75 ml) (at this time, the solution is suspended). The temperature of this suspension solution is very slowly (10 minutes to 40 minutes, preferably 25 minutes to 35 minutes, most preferably about 30 minutes), about 50 ° C. to 60 ° C., preferably about 55 ° C. The temperature is raised and stirring is continued at this temperature for about 10 to 30 minutes, preferably 15 to 25 minutes, and most preferably about 20 minutes (solution becomes transparent). After confirming the completion of the reaction by thin layer chromatography (hereinafter abbreviated as “TLC”), the solvent is concentrated and the resulting oily substance is crystallized to obtain Z-glutamic anhydride.
[0015]
3) Synthesis of Z-γ- ethylamidoglutamic acid Z-glutamic anhydride is dissolved in DMSO, while a mixture of ethylamine hydrochloride and triethylamine or sodium bicarbonate is dissolved in DMSO, both solutions are added and stirred at room temperature for 20 minutes. Then, the target Z-γ-ethylamidoglutamic acid can be obtained by performing extraction and purification thereafter. The DMSO used at this time needs to be sufficiently dried with a molecular sieve or the like.
As an extraction / purification method, for example, sodium hydrogen carbonate (saturated 10 ml) and 10 ml of water are added, the aqueous layer is extracted several times (for example, twice) with dichlorometal, and acidified so that the aqueous layer becomes PH1. . Thereafter, extraction was performed several times (for example, 3 times) with ethyl acetate, the ethyl acetate layer was dried over magnesium sulfate, the solvent was removed, and a residual oil was obtained. If this oil is dissolved in a small amount of ethyl acetate and separated and purified by a silica gel column, white crystalline Z-γ-ethylamidoglutamic acid can be obtained. In this case, with ethyl acetate and acetic acid (100: 1), the faster elution is α form (α position is ethylamidation), and the later elution is γ form (γ position is ethylamidation). According to the method, a γ-form in which the γ-position is ethylamidated at a ratio of γ-form: α-form = 3: 1 or more can be obtained more advantageously.
As an elution method, the eluent is eluted only with ethyl acetate, and then eluted with a 5% methanol ethyl acetate solution and further with a methanol solution. After confirming each fraction solution by TLC, the eluent is concentrated. Can also be mentioned.
[0016]
4) Removal of the protecting group and removal of the purified Z group are preferred in that catalytic reduction (hydrogenation) is a mild, harmless and clean method. Specifically, Z-γ-ethylamidoglutamic acid may be catalytically reduced with palladium or the like in a dioxane solution containing hydrochloric acid.
The removal of the Z group can be carried out by acid treatment such as liquid HF, sulfonic acids or HBr / AcOH in addition to the above catalytic reduction.
[0017]
After elimination of the Z group, palladium and the like are filtered, the solvent is concentrated, crystallized with ether, and then purified with an ion exchange resin (cation exchange resin: Amberlite IR-124, Dowex50w-x12). Good.
[0018]
(test)
In this test, the relationship between the reaction time and the yield in the synthesis of Z-Glu anhydride (anhydride) was examined.
[0019]
A suspension was prepared by adding 1.969 mg of Z-glutamic acid (Z-Glu-OH) to 15 ml of acetic anhydride with vigorous stirring, and the temperature of the suspension was changed from room temperature to 55 ° C. for 10 hours with a water bath. Minutes, 30 minutes, 60 minutes). And after all the solid melt | dissolved, it stirred for 20 to 60 minutes, keeping the temperature.
Thereafter, the solvent was concentrated under reduced pressure, and the oil was dried together with sodium hydroxide in an evaporating dish in a vacuum desiccator.
Crystallization was carried out by adding isopropyl ether / petroleum ether (1/1, v / v) little by little while cooling, followed by stirring and then returning to room temperature in 1 hour to cool the resulting crystals. Washed with petroleum ether.
Table 1 below shows the relationship between the temperature raising time, the reaction time, and the yield. In addition,-in the table | surface has shown the result which was not able to be obtained as a crystal | crystallization.
[0020]
[Table 1]
Figure 0004290844
[0021]
As a result, in order to obtain Z-glutamic anhydride, it is preferable to raise the temperature of the suspended solution very slowly (over about 30 minutes) to 55 ° C. and continue stirring at this temperature for about 20 minutes. found.
[0022]
【The invention's effect】
In the production of the present invention, by using an anhydride as a starting material for peptide bonds, it is possible to omit the introduction / desorption step of the carboxyl protecting group, and to obtain highly purified theanine with fewer steps. Moreover, since the introduction of ethylamine is carried out by a ring-opening reaction by aminolysis of an anhydride, it does not require a condensing agent, and is safe for the human body, and can be very inexpensive to produce.
Further, only one Z protecting group is required for the amino group, and the elimination reaction of the Z group can be easily performed by catalytic reduction (hydrogenation).
Furthermore, since almost no organic solvent or metal harmful to the human body is used, it can be suitably used as a food additive or a pharmaceutical raw material.

Claims (4)

グルタミン酸のアミノ基を保護したN保護グルタミン酸無水物を、ジメチルスルホキシドを用いて当該無水物のγ位を選択的にエチルアミド化させてN保護テアニンとし、次いでN保護基を脱離させる工程を有するテアニンの製造方法。N-protected glutamic anhydride in which the amino group of glutamic acid is protected is converted to N-protected theanine by selectively ethylamidating the γ-position of the anhydride using dimethyl sulfoxide, and then removing the N-protecting group. Manufacturing method. グルタミン酸のアミノ基をベンジルオキシカルボニル基(Z基)で保護したZ−グルタミン酸無水物を、ジメチルスルホキシドを用いて当該無水物のγ位を選択的にエチルアミド化させてZ−γ−エチルアミドグルタミン酸とし、次いでベンジルオキシカルボニル基(Z基)を脱離させてテアニンとする工程を有するテアニンの製造方法。Z-glutamic acid anhydride in which the amino group of glutamic acid is protected with benzyloxycarbonyl group (Z group) is selectively ethylamidated with dimethyl sulfoxide to γ-position of the anhydride to form Z-γ-ethylamidoglutamic acid. Then, a method for producing theanine, which comprises the step of removing the benzyloxycarbonyl group (Z group) to form theanine. 次の1)〜2)の工程を有するテアニンの製造方法。
1) グルタミン酸のアミノ基をベンジルオキシカルボニル基(Z基)で保護したZ−グルタミン酸無水物を、エチルアミン塩酸塩とトリエチルアミン又は炭酸水素ナトリウムの混液とともに、ジメチルスルホキシド中に加えてZ−γ−エチルアミドグルタミン酸を合成する工程、
2) 得られたZ−γ−エチルアミドグルタミン酸のZ基を脱離させる工程。
A method for producing theanine having the following steps 1) to 2).
1) Add Z-glutamic anhydride in which the amino group of glutamic acid is protected with a benzyloxycarbonyl group (Z group) together with a mixture of ethylamine hydrochloride and triethylamine or sodium hydrogen carbonate into dimethyl sulfoxide to add Z-γ-ethylamide. A step of synthesizing glutamic acid,
2) A step of eliminating the Z group of the obtained Z-γ-ethylamidoglutamic acid.
上記のZ−グルタミン酸無水物は、無水酢酸中にZ-グルタミン酸を加え、この溶液を10分〜40分かけて50℃〜60℃まで加温するとともに、その温度を保持しつつ10分〜30分攪拌し、この反応溶液を濃縮して得ることを特徴とする請求項2又は3に記載のテアニンの製造方法。The above Z-glutamic acid anhydride is obtained by adding Z-glutamic acid in acetic anhydride and heating this solution to 50 ° C. to 60 ° C. over 10 minutes to 40 minutes , while maintaining the temperature for 10 minutes to 30 minutes. The method for producing theanine according to claim 2 or 3, wherein the reaction solution is obtained by stirring for a minute and concentrating the reaction solution.
JP2000088975A 2000-03-28 2000-03-28 Method for producing theanine Expired - Lifetime JP4290844B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000088975A JP4290844B2 (en) 2000-03-28 2000-03-28 Method for producing theanine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000088975A JP4290844B2 (en) 2000-03-28 2000-03-28 Method for producing theanine

Publications (2)

Publication Number Publication Date
JP2001278848A JP2001278848A (en) 2001-10-10
JP4290844B2 true JP4290844B2 (en) 2009-07-08

Family

ID=18604785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000088975A Expired - Lifetime JP4290844B2 (en) 2000-03-28 2000-03-28 Method for producing theanine

Country Status (1)

Country Link
JP (1) JP4290844B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100734069B1 (en) 2005-05-19 2007-06-29 주식회사 카이로켐 Method for preparing N (5) -ethylglutamine

Also Published As

Publication number Publication date
JP2001278848A (en) 2001-10-10

Similar Documents

Publication Publication Date Title
JP3792777B2 (en) Method for producing 1-alkoxycarbonyl-3-phenylpropyl derivative
EA001948B1 (en) METHOD FOR PREPARING AND CLEANING N-ALKYLINATED DERIVATIVE ASPARTAM
EP0092933B1 (en) Process for producing alpha-l-aspartyl-l-phenylalanine methyl ester or its hydrochloride
JPH0699373B2 (en) Method for synthesizing N-alkylated α-amino acid
JP2752520B2 (en) 1- [N ▲ 22-((S) -ethoxycarbonyl) -3-phenylpropyl) -N ▲ 66-trifluoroacetyl] -L-lysyl-L-proline (lisinopril (Tfa) ethyl ester Purification method
JP4290844B2 (en) Method for producing theanine
JPH11130794A (en) Purification of aspartame derivative
JPS6257180B2 (en)
JP3577756B2 (en) Method for selectively producing N-protected glutamic acid γ-derivative
JP3657118B2 (en) Method for producing theanine
JP3665976B2 (en) Optical resolving agent and process for producing optically active N-tert-butyl-2-piperazinecarboxamide using the same
US3903077A (en) Direct synthesis of dopamine amino acid amides
Flouret et al. Convenient resolution method for the preparation of isoleucine optical isomers
HRP20020631A2 (en) Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycil-pyridinioalaninamides
CA2323678A1 (en) Process for the preparation of a tetrapeptide
JPH1045692A (en) Method for producing cyclohexyl amino acids
JPS59227850A (en) Synthesis of aspartame
JP5152180B2 (en) Method for producing valaciclovir
JP4564375B2 (en) Method for producing theanine
JP3178092B2 (en) Method for producing α-L-aspartyl-L-phenylalanine methyl ester hydrochloride
RU2072358C1 (en) Method for production of n-acetyl-phenyl alanine methionines
JP2003342259A (en) Method for producing optically active cispiperidine derivative
JP3554399B2 (en) Peptide derivatives
JPH01104034A (en) Production of n2-(1-carboxy-3-phenylpropyl)-l-lysine derivative
JPS585038B2 (en) Method for producing dipeptide ester

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050819

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081216

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090119

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090303

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090402

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4290844

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120410

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150410

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term